Surgical interventions on blood vessels in oncological practice

Abstract

Here we have analyzed our experience of using surgical interventions on blood vessels in oncological practice. In the period 2006-2009, surgical interventions on blood vessels were performed in 167 patients with malignant tumors. Out of those, local tumors were diagnosed in 86 patients, including 47 persons with tumors in the hepatoduodenal region and 39 with kidney cancer leading to inferior vena cava thrombosis. 81 patients that were in the remission phase of the oncological disease were operated on for obliterating vascular disease of the lower extremities and abdominal aortic aneurysm. Operations on blood vessels in patients with local tumors enabled us to increase the patients'operability, improve their life quality and life expectancy.

Keywords

vascular reconstruction / obliterating atherosclerosis of the lower extremities / local liver, pancreas and kidney tumors

References

[1] Гранов Д.А., Майстренко Д.К., Жеребцов Ф.К. и др. Роль сосудистых реконструкций в хирургии опухолей гепатопанкреатобилиарной зоны // Вести, хир. им. И.И. Грекова. 2008. Т. 167. № 5. С. 43-47.

[2] Давыдов М.И., Матвеев В.Б. Хирургическое лечение больных раком почки с опухолевым тромбозом почечной и нижней полой вен // Онкоурология. 2005. №2. С. 8-15.

[3] Майстренко Д.Н., Жеребцов Ф.К., Осовских В.В. и др. Современные диагностические технологии в определении тактики лечения больных с облитерирующим атеросклерозом сосудов нижних конечностей // Вести, хир. 2009. № 2. С. 41-46.

[4] Мерабишвили В.М. Злокачественные новообразования в мире, России, Санкт-Петербурге. СПб., 2007. С. 37-153.

[5] Патютко Ю.И., Котельников А.Г., Косырев В.ІО., Сагайдак И.В. Пути улучшения переносимости гастропанкреатодуоденальной резекции // Хирургия. 2002. № 10. С. 29-32.

[6] Покровский А.В. Клиническая ангиология. Т. 1. М.: Медицина, 2004. 804 с.

[7] Путов Н.В., Артемьева Н.Н., Коханенко Н.Ю. Рак поджелудочной железы. СПб.: Питер. 416 с.

[8] Щукин Д.В., Илюхин Ю.А. Хирургия опухолевых тромбов нижней полой вены при раке почки. Белгород, 2007. 196 с.

[9] Douglas В.Е. Resectable pancreatic cancer: The role for neoadjuvant/preoperative therapy // HPB. 2006. № 8. P. 365-368.

[10] Figueras J., Ibanez L., Ramos E. et al. Selection crate- ria for liver transplantation in early stage of hepatocellular carcinoma with cirrhosis // Liver Transpl. 2001. Vol. 7. P. 877-883.

[11] Garcea G., Lloydb T.D., Aylottb C. et al. The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours // Eur. J. Cancer. 2003. Vol. 39. P. 2150-2164.

[12] Hemming A.W., Reed M.A., Langham M.R. et al. Combined resection of the liver and inferior vena cava for hepatic malignancy //Ann. Surg. 2004. Vol. 239. P. 712-721.

[13] Lazenby J.M., Saif M.W. Palliative care from the beginning of treatment for advanced pancreatic cancer // J. Pancreas. 2010. Vol. 11. № 2. P. 154-157.

[14] Martin R.C.G., Scoggins C.R., Egnatashvili V. et al. Arterial and venous resection for pancreatic adenocarcinoma //Arch. Surg. 2009. Vol. 144. № 2. P. 154- 157.

[15] Oldhafer K.J., Lang H., Schlitt H.J. et al. Long-term experience after ex situ liver surgery // Surgery. May 2000. Vol. 127. №5. P.521.

[16] Sala M., Fuster J., Llovet J. et al. Pathological risk of recurrence after surgical resection for HCC // Liver. Transpl. 2004. Vol. 10. P. 1296-1302.

[17] Sugiura Y., Horio T., Aiko S. et al. Pancreatectomy for pancreatic cancer with reference to combined resection of the vessels, twenty nine year experience by a single surgeon // Keio J. Med. 2009. ѴЫ. 58. P. 103-109.

[18] TASC Working Group Trans-Atlantic Inter-Society, Consensus Management of Peripheral Arterial Disease // Int. Angiol. 2000. Vol. 19 (Suppl. 1). 304 p.

RIGHTS & PERMISSIONS

Granov A.M., Maistrenko D.N., Polysalov V.N., Granov D.A., Pavlovskii A.V., Shkolnik M.I., Zherebtsov F.K., Osovskikh V.V.